BSE filing, NSE: KTKBANK. Summary written from the filing by ALFA Finder's alert engine.
Karnataka Bank Ltd: key numbers
- Share price
- ₹311.00
- Market cap
- ₹11,770 Cr
- Revenue (annual)
- ₹8,918 Cr
- Net profit (annual)
- ₹1,311 Cr
- P/E (TTM)
- 7.6×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 16.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Karnataka Bank Ltd
All →Karnataka Bank Investor Presentation: Key Takeaways
Q2 FY27: PAT ₹436 cr (+36.6% YoY), NII ₹982 cr (+34.9% YoY), gross advances ₹92,015 cr (+25% YoY), GNPA 2.27% (-106 bps YoY). Asset quality and CASA are the focus.
Karnataka Bank Results Update
Karnataka Bank's board approved Q2 FY27 results, with net profit of Rs.435.89 crore, up 37% YoY. Aggregate business hit an all-time high of Rs.2,07,132.41 crore.
Karnataka Bank Q2 FY27 Results: Net Profit ₹435.9 Cr, Up 36.6% YoY
Karnataka Bank Ltd reported revenue from operations of ₹2,504 Cr (+14.9% YoY) and net profit of ₹435.9 Cr (+36.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹435.9 Cr · +36.6% YoY
Karnataka Bank Management Change
Karnataka Bank's Chief Operating Officer, Mr. Raja B S, has resigned from the Bank's services, effective October 19, 2026, to pursue other career interests.
Karnataka Bank Other Announcement
Karnataka Bank Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Karnataka Bank Board Meeting Date
Karnataka Bank scheduled a board meeting on October 28, 2026, to consider unaudited standalone and consolidated financial results for the quarter and half year ended September 30.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date